Development of a Questionnaire to Evaluate Patient Expectations for Breast Reconstruction in Women With Breast Cancer or Other Conditions

Sponsor
Memorial Sloan Kettering Cancer Center (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT00471601
Collaborator
National Cancer Institute (NCI) (NIH), McMaster University (Other), University College, London (Other), The New School for Social Research (Other)
357
4
1
186.1
89.3
0.5

Study Details

Study Description

Brief Summary

RATIONALE: A questionnaire that evaluates a patient's expectations about breast reconstruction surgery may help doctors improve patient education before surgery and increase patient satisfaction after surgery.

PURPOSE: This clinical trial is developing a questionnaire to evaluate patient expectations for breast reconstruction in women with breast cancer or other conditions.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: counseling intervention
  • Behavioral: questionnaire administration
  • Behavioral: psychosocial assessment and care
  • Behavioral: quality-of-life assessment
N/A

Detailed Description

OBJECTIVES:
  • Develop and validate a questionnaire to evaluate preoperative expectations about breast reconstruction in women with breast cancer or other conditions.

  • Determine variations in expectations related to patient characteristics.

  • Develop educational modules to help patients understand realistic outcomes.

  • Identify patient groups at risk for dissatisfaction.

OUTLINE: This is a 3-part study.

  • Part 1 (first 80 patients): Both preoperative and postoperative patients (50 patients total) undergo an interview by a research study assistant about their expectations for breast reconstructive surgery. Some of these patients will also complete a pilot version of a questionnaire about their expectations for breast reconstructive surgery (30 patients total).

  • Part 2 (next 200 patients): Preoperative patients complete questionnaires (the preliminary questionnaire developed after part 1 and the MSKCC BREAST-Q [Reconstruction Module]) about their expectations for breast reconstructive surgery after patient education about breast reconstructive surgery. Some of these patients (100 patients) also complete the Brief Cope addressing emotional expression and emotional processing styles of coping, Impact of Events Scale, and Life Orientation Test-Revised (LOT-R) questionnaires.

  • Part 3 (final 200 patients): Preoperative patients complete a questionnaire (final questionnaire developed after part 2) about their expectations for breast reconstructive surgery after patient education about breast reconstruction and once after surgery. Patients also complete the Breast Reconstruction Outcomes Questionnaire (MSKCC BREAST-Q) once before surgery (after patient education) and once after surgery measuring patient satisfaction and quality of life. A small group of patients complete the Body Image Scale (BIS) and the LOT-R addressing body image, sexuality, personal well-being, and lifestyle.

Study Design

Study Type:
Interventional
Actual Enrollment :
357 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Measuring Patient Expectations for Breast Reconstruction: Development and Validation of a Patient-Reported Outcomes Instrument
Study Start Date :
Mar 1, 2007
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Sep 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Interviews/Questionnaires

The primary intervention in part 1 includes the interview for item generation with 50 women and the pilot-testing with a separate group of n = 30 women. The primary intervention in part 2 and 3 is the administration of the questionnaire. In part 3, along with the questionnaire being developed, the Body Image Scale (BIS), the Life Orientation Test-Revised (LOT-R), and the upcoming MSKCC BREAST-Q will be given to determine convergent and discriminant construct validity. No other therapeutic or diagnostic agents will be administered.

Behavioral: counseling intervention

Behavioral: questionnaire administration

Behavioral: psychosocial assessment and care

Behavioral: quality-of-life assessment

Outcome Measures

Primary Outcome Measures

  1. Item reduction [2 years]

  2. Psychometric evaluation [2 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Female.

  • Age > or = to 18 to 75 years.

  • Patients who are presenting for consultation about breast reconstruction

Exclusion Criteria:
  • Inability to speak or understanding English

  • Inability to provide meaningful informed consent due to physical, cognitive, or psychiatric disability.

  • Prior breast reconstruction surgery.

Contacts and Locations

Locations

Site City State Country Postal Code
1 New School for Social Research New York New York United States 10003
2 Memorial Sloan Kettering Cancer Center New York New York United States 10065
3 McMaster Children's Hospital at Hamilton Health Sciences Hamilton Ontario Canada L8N 3Z5
4 University College of London Hospitals London England United Kingdom WIT 3AA

Sponsors and Collaborators

  • Memorial Sloan Kettering Cancer Center
  • National Cancer Institute (NCI)
  • McMaster University
  • University College, London
  • The New School for Social Research

Investigators

  • Principal Investigator: Colleen McCarthy, MD, Memorial Sloan Kettering Cancer Center
  • Principal Investigator: Peter G. Cordeiro, MD, Memorial Sloan Kettering Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT00471601
Other Study ID Numbers:
  • 07-024
  • P30CA008748
  • MSKCC-07024
First Posted:
May 10, 2007
Last Update Posted:
Oct 4, 2021
Last Verified:
Oct 1, 2021

Study Results

No Results Posted as of Oct 4, 2021